HedgeChatter

  • Home /
  • Tag Archives

MNTA

U.S. Court of Appeals Denied Momenta Pharmaceuticals Petition for Rehearing En Banc in Safe-Harbor Case

[at noodls] – CAMBRIDGE, Mass., Nov. 20, 2012 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced … moreView todays social media effects on MNTAView the latest stocks trending across Twitter. Click to view dashboard […]

November 20, 2012 Bystocknews , Comments Off on U.S. Court of Appeals Denied Momenta Pharmaceuticals Petition for Rehearing En Banc in Safe-Harbor Case read more

Momenta Pharmaceuticals Reports Third Quarter 2012 Financial Results

[at noodls] – CAMBRIDGE, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today reported … moreView todays social media effects on MNTAView the latest stocks trending across Twitter. Click to view dashboard […]

November 7, 2012 Bystocknews , Comments Off on Momenta Pharmaceuticals Reports Third Quarter 2012 Financial Results read more

Momenta Pharmaceuticals Announces Date of Third Quarter 2012 Financial Results Conference Call

[at noodls] – CAMBRIDGE, Mass., Oct. 18, 2012 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will release … moreView todays social media effects on MNTAView the latest stocks trending across Twitter. Click to view dashboard […]

October 18, 2012 Bystocknews , Comments Off on Momenta Pharmaceuticals Announces Date of Third Quarter 2012 Financial Results Conference Call read more